Correlation Between Reviva Pharmaceuticals and Oncorus
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Oncorus, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Oncorus.
Diversification Opportunities for Reviva Pharmaceuticals and Oncorus
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reviva and Oncorus is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Oncorus go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Oncorus
If you would invest 9.80 in Reviva Pharmaceuticals Holdings on August 27, 2024 and sell it today you would earn a total of 11.20 from holding Reviva Pharmaceuticals Holdings or generate 114.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Oncorus
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reviva Pharmaceuticals and Oncorus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Oncorus
The main advantage of trading using opposite Reviva Pharmaceuticals and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
| Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |